Evercore Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Hold
4,000
﹤0.01% 333
2026
Q1
$259K Hold
4,000
﹤0.01% 351
2025
Q4
$269K Hold
4,000
﹤0.01% 355
2025
Q3
$293K Hold
4,000
﹤0.01% 351
2025
Q2
$208K Hold
4,000
﹤0.01% 386
2025
Q1
$255K Buy
+4,000
New +$232K ﹤0.01% 362
2024
Q4
Sell
-4,143
Closed -$237K 428
2024
Q3
$237K Hold
4,143
﹤0.01% 377
2024
Q2
$217K Buy
+4,143
New +$182K ﹤0.01% 386
2023
Q1
Sell
-4,143
Closed -$236K 409
2022
Q4
$236K Buy
+4,143
New +$212K ﹤0.01% 360

Other funds holding HALO

Evercore Wealth Management's HALO Position: Q2 2026 in Review

Evercore Wealth Management held its Halozyme (HALO) position steady in Q2 2026 at 4,000 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Evercore Wealth Management first reported a position in HALO in Q4 2022 and has held it in 9 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Evercore Wealth Management held 4,000 shares of Halozyme worth $313K as of Q2 2026.
  • Evercore Wealth Management left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Evercore Wealth Management's portfolio in Q2 2026, its #333 holding.
  • Evercore Wealth Management first reported a position in Halozyme in Q4 2022 and has held it in 9 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.